CLINICAL_TRIALS
trial_result
· 2017-05-19
Clinical Trial Update: Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA) [Phase 2]
Summary
Phase 2 study evaluating imatinib, a c-KIT inhibitor, in adults with severe refractory asthma has completed and posted results in 2017. The trial assessed the e…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2017-05-19